↓ Skip to main content

Anticholinergic Medication Use and Risk of Pneumonia in Elderly Adults: A Nested Case–Control Study

Overview of attention for article published in Journal of the American Geriatrics Society, February 2016

About this Attention Score

  • Good Attention Score compared to outputs of the same age (70th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
10 X users

Readers on

mendeley
48 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Anticholinergic Medication Use and Risk of Pneumonia in Elderly Adults: A Nested Case–Control Study
Published in
Journal of the American Geriatrics Society, February 2016
DOI 10.1111/jgs.13932
Pubmed ID
Authors
Abstract

To examine the risk of community-acquired pneumonia (CAP) associated with the use of anticholinergic medications in elderly adults. Nested case-control study. A regional Medicare Advantage healthcare plan (2009-2010). Participants were Medicare Advantage Plan enrollees aged 65 and older with at least one inpatient and one outpatient claim with no history of CAP between January 1 and June 30, 2009. Cases were identified as enrollees with an incident diagnosis of CAP, between July 1, 2009, and December 31, 2010 (n = 291). Four age- and sex-matched controls (n = 1,164) were identified per case using incidence density sampling. Anticholinergic prescription 30 days preceding the event date was the primary exposure. Anticholinergic exposure was defined based on the Anticholinergic Drug Scale (ADS). A conditional logistic regression model stratified on matched case-control sets was used, with exposure to a Level 1, 2, or 3 anticholinergic on the ADS as the main independent variable; CAP as the main outcome variable; and risk factors for CAP as additional explanatory variables. After controlling for risk factors, overall use of anticholinergic medications was significantly associated with risk of pneumonia (odds ratio (OR) = 1.65, 95% confidence interval (CI) = 1.20-2.28). The risk of pneumonia remained significant across the different exposure periods, although use of higher-level (ADS Level 2 or 3) anticholinergics was not associated with pneumonia risk (OR = 1.16, 95% CI = 0.70-1.96). Overall use of anticholinergic medications, but not higher-level drugs, was associated with greater risk of CAP compared to no use after controlling for other factors. More research is needed to better understand the role of potent anticholinergic medications on pneumonia risk in elderly adults.

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 10 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 48 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
United States 2 4%
Unknown 46 96%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Researcher 7 15%
Other 6 13%
Student > Ph. D. Student 4 8%
Student > Master 4 8%
Professor > Associate Professor 4 8%
Other 5 10%
Unknown 18 38%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 13 27%
Pharmacology, Toxicology and Pharmaceutical Science 4 8%
Engineering 2 4%
Biochemistry, Genetics and Molecular Biology 1 2%
Nursing and Health Professions 1 2%
Other 4 8%
Unknown 23 48%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 November 2018.
All research outputs
#8,314,274
of 29,447,391 outputs
Outputs from Journal of the American Geriatrics Society
#5,427
of 9,456 outputs
Outputs of similar age
#94,773
of 319,087 outputs
Outputs of similar age from Journal of the American Geriatrics Society
#55
of 94 outputs
Altmetric has tracked 29,447,391 research outputs across all sources so far. This one has received more attention than most of these and is in the 71st percentile.
So far Altmetric has tracked 9,456 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 23.4. This one is in the 42nd percentile – i.e., 42% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 319,087 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.
We're also able to compare this research output to 94 others from the same source and published within six weeks on either side of this one. This one is in the 41st percentile – i.e., 41% of its contemporaries scored the same or lower than it.